Skip to content
10-Q

Quarterly Report

INTELLIA THERAPEUTICS, INC. NTLA

0000950170-25-104987

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 107.35M sh
Shares Diluted Q2 2025 · Jun 30, 2025 103.73M sh
Shares Diluted Q2 2025 · Jun 30, 2025 103.62M sh
Shares Diluted Q2 2025 · Jun 30, 2024 96.98M sh
Shares Diluted Q2 2025 · Jun 30, 2024 96.24M sh
Capex Q2 2025 · Jun 30, 2025 $974K
Capex Q2 2025 · Jun 30, 2024 $3.52M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$248.55M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$178.85M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $156.17M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $189.18M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $130.85M
Stockholders Equity Q2 2025 · Jun 30, 2025 $715.26M
Stockholders Equity Q2 2025 · Mar 31, 2025 $779.92M
Stockholders Equity Q2 2025 · Dec 31, 2024 $871.96M
Stockholders Equity Q2 2025 · Jun 30, 2024 $971.06M
Stockholders Equity Q2 2025 · Mar 31, 2024 $1.04B
Stockholders Equity Q2 2025 · Dec 31, 2023 $1.05B
Current Liabilities Q2 2025 · Jun 30, 2025 $95.5M
Current Liabilities Q2 2025 · Dec 31, 2024 $110.85M
Total Liabilities Q2 2025 · Jun 30, 2025 $183.64M
Total Liabilities Q2 2025 · Dec 31, 2024 $319.06M
Current Assets Q2 2025 · Jun 30, 2025 $495.95M
Current Assets Q2 2025 · Dec 31, 2024 $639.86M
Total Assets Q2 2025 · Jun 30, 2025 $898.89M
Total Assets Q2 2025 · Dec 31, 2024 $1.19B
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.98
Eps Diluted Q2 2025 · Jun 30, 2025 −$2.08
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.52
Eps Diluted Q2 2025 · Jun 30, 2024 −$2.64
Eps Basic Q2 2025 · Jun 30, 2025 −$0.98
Eps Basic Q2 2025 · Jun 30, 2025 −$2.08
Eps Basic Q2 2025 · Jun 30, 2024 −$1.52
Eps Basic Q2 2025 · Jun 30, 2024 −$2.64
Sga Expense Q2 2025 · Jun 30, 2025 $27.21M
Sga Expense Q2 2025 · Jun 30, 2025 $56.21M
Sga Expense Q2 2025 · Jun 30, 2024 $31.79M
Sga Expense Q2 2025 · Jun 30, 2024 $62.88M
Rd Expense Q2 2025 · Jun 30, 2025 $97.04M
Rd Expense Q2 2025 · Jun 30, 2025 $205.46M
Rd Expense Q2 2025 · Jun 30, 2024 $114.21M
Rd Expense Q2 2025 · Jun 30, 2024 $226.05M
Net Income Q2 2025 · Jun 30, 2025 −$101.26M
Net Income Q2 2025 · Jun 30, 2025 −$215.58M
Net Income Q2 2025 · Mar 31, 2025 −$114.33M
Net Income Q2 2025 · Jun 30, 2024 −$146.98M
Net Income Q2 2025 · Jun 30, 2024 −$254.41M
Net Income Q2 2025 · Mar 31, 2024 −$107.44M
Operating Income Q2 2025 · Jun 30, 2025 −$110M
Operating Income Q2 2025 · Jun 30, 2025 −$230.8M
Operating Income Q2 2025 · Jun 30, 2024 −$139.04M
Operating Income Q2 2025 · Jun 30, 2024 −$253.05M
Revenue Q2 2025 · Jun 30, 2025 $14.25M
Revenue Q2 2025 · Jun 30, 2025 $30.87M
Revenue Q2 2025 · Jun 30, 2024 $6.96M
Revenue Q2 2025 · Jun 30, 2024 $35.89M